Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study

Volume: 140, Pages: 30 - 35
Published: Apr 1, 2016
Abstract
Introduction Although plasminogen activator inhibitor (PAI-1) plays a key regulatory role in fibrinolysis, it has not been clearly shown to independently predict cardiovascular disease (CVD) among individuals without prior CVD. We investigated, in the Framingham Heart Study offspring cohort, whether PAI-1 predicted CVD risk among individuals without prior CVD. Methods Plasma PAI-1 antigen and tissue plasminogen activator (TPA) antigen were...
Paper Details
Title
Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study
Published Date
Apr 1, 2016
Volume
140
Pages
30 - 35
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.